Company Update Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Marksans Pharma Ltd''s subsidiary Relonchem Limited in UK receives marketing authorisation for its products from UK MHRA